{
    "xml": "<topic id=\"PHP908\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/amiodarone-hydrochloride\" basename=\"amiodarone-hydrochloride\" title=\"AMIODARONE HYDROCHLORIDE\">\n<title>AMIODARONE HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_118\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\">Amiodarone</xref>\n</p>\n<data name=\"vtmid\">69236009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_252514551\" title=\"Antiarrhythmics\">Antiarrhythmics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP52393\" outputclass=\"indicationsAndDose\" rev=\"1.36\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of arrhythmias, particularly when other drugs are ineffective or contra-indicated (including paroxysmal supraventricular, nodal and ventricular tachycardias, atrial fibrillation and flutter, ventricular fibrillation, and tachyarrhythmias associated with Wolff-Parkinson-White syndrome) (initiated in hospital or under specialist supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg 3 times a day for 1 week, then reduced to 200&#8239;mg twice daily for a further week, followed by maintenance dose, usually 200&#8239;mg daily or the minimum dose required to control arrhythmia.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;mg/kg, to be given over 20&#8211;120 minutes with ECG monitoring, subsequent infusions given if necessary according to response; maximum 1.2&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 300&#8239;mg, dose to be considered after administration of adrenaline, dose should be given from a pre-filled syringe or diluted in 20&#8239;mL Glucose 5%, then (by intravenous injection) 150&#8239;mg if required, followed by (by intravenous infusion) 900&#8239;mg/24 hours.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52512\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<title>General contraindications:</title>\n<p>\n<ph outputclass=\"contraindication\">Avoid in severe conduction disturbances (unless pacemaker fitted)</ph>; <ph outputclass=\"contraindication\">avoid in sinus node disease (unless pacemaker fitted)</ph>; <ph outputclass=\"contraindication\">iodine sensitivity</ph>; <ph outputclass=\"contraindication\">sino-atrial heart block (except in cardiac arrest)</ph>; <ph outputclass=\"contraindication\">sinus bradycardia (except in cardiac arrest)</ph>; <ph outputclass=\"contraindication\">thyroid dysfunction</ph>\n</p>\n<sectiondiv outputclass=\"additionalContraindications\">\n<p outputclass=\"title\">Specific contraindications:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"contraindication\">avoid bolus injection in cardiomyopathy</ph>; <ph outputclass=\"contraindication\">avoid bolus injection in congestive heart failure</ph>; <ph outputclass=\"contraindication\">avoid in circulatory collapse</ph>; <ph outputclass=\"contraindication\">avoid in severe arterial hypotension</ph>; <ph outputclass=\"contraindication\">avoid in severe respiratory failure</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52555\" outputclass=\"cautions\" rev=\"1.27\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<title>General cautions:</title>\r\n<p>\r\n<ph outputclass=\"caution\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">conduction disturbances (in excessive dosage)</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">heart failure</ph>; <ph outputclass=\"caution\">hypokalaemia</ph>; <ph outputclass=\"caution\">severe bradycardia (in excessive dosage)</ph>\r\n</p>\r\n<sectiondiv outputclass=\"additionalCautions\">\r\n<p outputclass=\"title\">Specific cautions:</p>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With intravenous use</p>\r\n<p>\r\n<ph outputclass=\"caution\">moderate and transient fall in blood pressure (circulatory collapse precipitated by rapid administration or overdosage)</ph>; <ph outputclass=\"caution\">severe hepatocellular toxicity</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP52387\" outputclass=\"interactions\" rev=\"1.21\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (amiodarone).</p>\n<p>Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped.</p>\n<p>Use extreme caution or avoid concomitant use of drugs that prolong QT interval.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Risk of severe bradycardia or heart block when amiodarone is used in combination with sofosbuvir and daclatasvir for Hepatitis C.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52328\" outputclass=\"sideEffects\" rev=\"1.13\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bradycardia</ph>; <ph outputclass=\"sideEffect\">hyperthyroidism</ph>; <ph outputclass=\"sideEffect\">hypothyroidism</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">persistent slate grey skin discoloration</ph>; <ph outputclass=\"sideEffect\">phototoxicity</ph>; <ph outputclass=\"sideEffect\">pulmonary toxicity (including pneumonitis and fibrosis)</ph>; <ph outputclass=\"sideEffect\">raised serum transaminases (may require dose reduction or withdrawal if accompanied by acute liver disorders)</ph>; <ph outputclass=\"sideEffect\">reversible corneal microdeposits (sometimes with night glare)</ph>; <ph outputclass=\"sideEffect\">sleep disorders</ph>; <ph outputclass=\"sideEffect\">taste disturbances</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Conduction disturbances</ph>; <ph outputclass=\"sideEffect\">onset or worsening of arrhythmia</ph>; <ph outputclass=\"sideEffect\">peripheral myopathy (usually reversible on withdrawal)</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy (usually reversible on withdrawal)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">aplastic anaemia</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">benign intracranial hypertension</ph>; <ph outputclass=\"sideEffect\">bronchospasm (in patients with severe respiratory failure)</ph>; <ph outputclass=\"sideEffect\">chronic liver disease</ph>; <ph outputclass=\"sideEffect\">cirrhosis</ph>; <ph outputclass=\"sideEffect\">epididymo-orchitis</ph>; <ph outputclass=\"sideEffect\">exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">haemolytic anaemia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypersensitivity</ph>; <ph outputclass=\"sideEffect\">impaired vision due to optic neuritis or optic neuropathy (including blindness)</ph>; <ph outputclass=\"sideEffect\">impotence</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">sinus arrest</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">vasculitis</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hot flushes</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">respiratory distress syndrome</ph>; <ph outputclass=\"sideEffect\">sweating</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">injection-site reactions</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">anaphylaxis on rapid injection</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Corneal microdeposits</p>\n<p>Most patients taking amiodarone develop corneal microdeposits (reversible on withdrawal of treatment); these rarely interfere with vision, but drivers may be dazzled by headlights at night. However, if vision is impaired or if optic neuritis or optic neuropathy occur, amiodarone must be stopped to prevent blindness and expert advice sought.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Thyroid function</p>\n<p>Amiodarone contains iodine and can cause disorders of thyroid function; both hypothyroidism and hyperthyroidism can occur. Thyrotoxicosis may be very refractory, and amiodarone should usually be withdrawn at least temporarily to help achieve control; treatment with carbimazole may be required. Hypothyroidism can be treated with replacement therapy without withdrawing amiodarone if it is essential; careful supervision is required.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Hepatotoxicity</p>\n<p>Amiodarone is also associated with hepatotoxicity and treatment should be discontinued if severe liver function abnormalities or clinical signs of liver disease develop.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Pulmonary toxicity</p>\n<p>Pneumonitis should always be suspected if new or progressive shortness of breath or cough develops in a patient taking amiodarone.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Peripheral neuropathy</p>\n<p>Fresh neurological symptoms should raise the possibility of peripheral neuropathy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52376\" outputclass=\"pregnancy\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Possible risk of neonatal goitre; use only if no alternative.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52565\" outputclass=\"breastFeeding\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid; present in milk in significant amounts; theoretical risk of neonatal hypothyroidism from release of iodine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52297\" outputclass=\"monitoringRequirements\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Thyroid function tests should be performed before treatment and then every 6 months. Clinical assessment of thyroid function alone is unreliable. Thyroxine (T4) may be raised in the absence of hyperthyroidism; therefore tri-iodothyronine (T3), T4, and thyroid-stimulating hormone (thyrotrophin, TSH) should all be measured. A raised T3 and T4 with a very low or undetectable TSH concentration suggests the development of thyrotoxicosis.</p>\n<p>Liver function tests required before treatment and then every 6 months.</p>\n<p>Serum potassium concentration should be measured before treatment.</p>\n<p>Chest x-ray required before treatment.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>ECG monitoring and resuscitation facilities must be available.</p>\n<p>Monitor liver transaminases closely.</p>\n</sectiondiv>\n<sectiondiv>\n<p>If concomitant use of amiodarone with sofosbuvir and daclatasvir cannot be avoided because other anti-arrhythmics are not tolerated or contraindicated, patients should be closely monitored, particularly during the first weeks of treatment.</p>\n<p>Patients at high risk of bradycardia should be monitored continuously for 48 hours in an appropriate clinical setting after starting concomitant treatment.</p>\n<p>Patients who have stopped amiodarone within the last few months and need to start sofosbuvir and daclatasvir should be monitored.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52593\" outputclass=\"directionsForAdministration\" rev=\"1.14\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Cordarone X</i>\n<tm tmtype=\"reg\"/>), give continuously or intermittently in Glucose 5%. Suggested initial infusion volume 250&#8239;mL given over 20&#8211;120 minutes; for repeat infusions up to 1.2&#8239;g in max. 500&#8239;mL; should not be diluted to less than 600&#8239;micrograms/mL. See cardio-pulmonary resuscitation for details of infusion in extreme emergency. Incompatible with Sodium Chloride infusion fluids; avoid equipment containing the plasticizer di-2-ethylhexphthalate (DEHP).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>For administration<i> by mouth</i>, tablets may be crushed and dispersed in water; injection solution should <b>not</b> be given orally (irritant).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52366\" outputclass=\"patientAndCarerAdvice\" rev=\"1.28\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Because of the possibility of phototoxic reactions, patients should be advised to shield the skin from light during treatment and for several months after discontinuing amiodarone; a wide-spectrum sunscreen to protect against both long-wave ultraviolet and visible light should be used.</p>\n</sectiondiv>\n<sectiondiv>\n<p>If taking amiodarone with sofosbuvir and daclatasvir, patients and their carers should be told how to recognise signs and symptoms of bradycardia and heart block and advised to seek immediate medical attention if symptoms such as shortness of breath, light-headedness, palpitations, fainting, unusual tiredness or chest pain develop.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP908-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/amiodarone-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution, powder</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75035\" title=\"Tablet\" namespace=\"/drugs/amiodarone-hydrochloride/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75041\" title=\"Solution for injection\" namespace=\"/drugs/amiodarone-hydrochloride/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97237\" namespace=\"/guidance/adverse-reactions-to-drugs\" title=\"Adverse reactions to drugs\" count=\"1\" rel=\"backlink\">Adverse reactions to drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e11910\" href=\"#bnf_d1e11910\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e11910</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e12263\" href=\"#bnf_d1e12263\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e12263</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e12492\" href=\"#bnf_d1e12492\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e12492</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e12541\" href=\"#bnf_d1e12541\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e12541</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69436\" href=\"#bnf_d1e69436\" namespace=\"/interactions/list-of-drug-interactions/antivirals/sofosbuvir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69436</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1285\" namespace=\"/interactions/list-of-drug-interactions/antivirals/sofosbuvir\" title=\"Sofosbuvir\" count=\"1\" rel=\"backlink\">Sofosbuvir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e68600\" href=\"#bnf_d1e68600\" namespace=\"/interactions/list-of-drug-interactions/antivirals/simeprevir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e68600</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1298\" namespace=\"/interactions/list-of-drug-interactions/antivirals/simeprevir\" title=\"Simeprevir\" count=\"1\" rel=\"backlink\">Simeprevir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e68029\" href=\"#bnf_d1e68029\" namespace=\"/interactions/list-of-drug-interactions/antivirals/daclatasvir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e68029</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1347\" namespace=\"/interactions/list-of-drug-interactions/antivirals/daclatasvir\" title=\"Daclatasvir\" count=\"1\" rel=\"backlink\">Daclatasvir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e67589\" href=\"#bnf_d1e67589\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ledipasvir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e67589</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1379\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ledipasvir\" title=\"Ledipasvir\" count=\"1\" rel=\"backlink\">Ledipasvir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78105\" namespace=\"/treatment-summaries/cardiopulmonary-resuscitation\" title=\"Cardiopulmonary resuscitation\" count=\"4\" rel=\"backlink\">Cardiopulmonary resuscitation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78291\" namespace=\"/treatment-summaries/arrhythmias\" title=\"Arrhythmias\" count=\"20\" rel=\"backlink\">Arrhythmias</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_118\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"Amiodarone\" count=\"1\" rel=\"link\">Amiodarone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75035\" namespace=\"/drugs/amiodarone-hydrochloride/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75041\" namespace=\"/drugs/amiodarone-hydrochloride/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP908",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/amiodarone-hydrochloride",
    "basename": "amiodarone-hydrochloride",
    "title": "AMIODARONE HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_118",
            "label": "Amiodarone"
        }
    ],
    "vtmid": "69236009",
    "drugClassification": [
        "Antiarrhythmics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of arrhythmias, particularly when other drugs are ineffective or contra-indicated (including paroxysmal supraventricular, nodal and ventricular tachycardias, atrial fibrillation and flutter, ventricular fibrillation, and tachyarrhythmias associated with Wolff-Parkinson-White syndrome) (initiated in hospital or under specialist supervision)",
                        "html": "Treatment of arrhythmias, particularly when other drugs are ineffective or contra-indicated (including paroxysmal supraventricular, nodal and ventricular tachycardias, atrial fibrillation and flutter, ventricular fibrillation, and tachyarrhythmias associated with Wolff-Parkinson-White syndrome) (initiated in hospital or under specialist supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "200 mg 3 times a day for 1 week, then reduced to 200 mg twice daily for a further week, followed by maintenance dose, usually 200 mg daily or the minimum dose required to control arrhythmia.",
                        "html": "<p>200&#8239;mg 3 times a day for 1 week, then reduced to 200&#8239;mg twice daily for a further week, followed by maintenance dose, usually 200&#8239;mg daily or the minimum dose required to control arrhythmia.</p>"
                    },
                    {
                        "textContent": "Initially 5 mg/kg, to be given over 20&#8211;120 minutes with ECG monitoring, subsequent infusions given if necessary according to response; maximum 1.2 g per day.",
                        "html": "<p>Initially 5&#8239;mg/kg, to be given over 20&#8211;120 minutes with ECG monitoring, subsequent infusions given if necessary according to response; maximum 1.2&#8239;g per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation",
                        "html": "Ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 300 mg, dose to be considered after administration of adrenaline, dose should be given from a pre-filled syringe or diluted in 20 mL Glucose 5%, then (by intravenous injection) 150 mg if required, followed by (by intravenous infusion) 900 mg/24 hours.",
                        "html": "<p>Initially 300&#8239;mg, dose to be considered after administration of adrenaline, dose should be given from a pre-filled syringe or diluted in 20&#8239;mL Glucose 5%, then (by intravenous injection) 150&#8239;mg if required, followed by (by intravenous infusion) 900&#8239;mg/24 hours.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid in severe conduction disturbances (unless pacemaker fitted)",
                "html": "Avoid in severe conduction disturbances (unless pacemaker fitted)"
            },
            {
                "type": "contraindications",
                "textContent": "avoid in sinus node disease (unless pacemaker fitted)",
                "html": "avoid in sinus node disease (unless pacemaker fitted)"
            },
            {
                "type": "contraindications",
                "textContent": "iodine sensitivity",
                "html": "iodine sensitivity"
            },
            {
                "type": "contraindications",
                "textContent": "sino-atrial heart block (except in cardiac arrest)",
                "html": "sino-atrial heart block (except in cardiac arrest)"
            },
            {
                "type": "contraindications",
                "textContent": "sinus bradycardia (except in cardiac arrest)",
                "html": "sinus bradycardia (except in cardiac arrest)"
            },
            {
                "type": "contraindications",
                "textContent": "thyroid dysfunction",
                "html": "thyroid dysfunction"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid bolus injection in cardiomyopathy",
                "html": "avoid bolus injection in cardiomyopathy",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid bolus injection in congestive heart failure",
                "html": "avoid bolus injection in congestive heart failure",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid in circulatory collapse",
                "html": "avoid in circulatory collapse",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid in severe arterial hypotension",
                "html": "avoid in severe arterial hypotension",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid in severe respiratory failure",
                "html": "avoid in severe respiratory failure",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "conduction disturbances (in excessive dosage)",
                "html": "conduction disturbances (in excessive dosage)"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "heart failure",
                "html": "heart failure"
            },
            {
                "type": "cautions",
                "textContent": "hypokalaemia",
                "html": "hypokalaemia"
            },
            {
                "type": "cautions",
                "textContent": "severe bradycardia (in excessive dosage)",
                "html": "severe bradycardia (in excessive dosage)"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "moderate and transient fall in blood pressure (circulatory collapse precipitated by rapid administration or overdosage)",
                "html": "moderate and transient fall in blood pressure (circulatory collapse precipitated by rapid administration or overdosage)",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "severe hepatocellular toxicity",
                "html": "severe hepatocellular toxicity",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (amiodarone).\n\nAmiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped.\n\nUse extreme caution or avoid concomitant use of drugs that prolong QT interval.",
                "html": "<p>Appendix 1 (amiodarone).</p><p>Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped.</p><p>Use extreme caution or avoid concomitant use of drugs that prolong QT interval.</p>"
            },
            {
                "type": "general",
                "textContent": "Risk of severe bradycardia or heart block when amiodarone is used in combination with sofosbuvir and daclatasvir for Hepatitis C.",
                "html": "<p>Risk of severe bradycardia or heart block when amiodarone is used in combination with sofosbuvir and daclatasvir for Hepatitis C.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Bradycardia",
                        "html": "Bradycardia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperthyroidism",
                        "html": "hyperthyroidism",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypothyroidism",
                        "html": "hypothyroidism",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "persistent slate grey skin discoloration",
                        "html": "persistent slate grey skin discoloration",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "phototoxicity",
                        "html": "phototoxicity",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pulmonary toxicity (including pneumonitis and fibrosis)",
                        "html": "pulmonary toxicity (including pneumonitis and fibrosis)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "raised serum transaminases (may require dose reduction or withdrawal if accompanied by acute liver disorders)",
                        "html": "raised serum transaminases (may require dose reduction or withdrawal if accompanied by acute liver disorders)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "reversible corneal microdeposits (sometimes with night glare)",
                        "html": "reversible corneal microdeposits (sometimes with night glare)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sleep disorders",
                        "html": "sleep disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "taste disturbances",
                        "html": "taste disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Conduction disturbances",
                        "html": "Conduction disturbances",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "onset or worsening of arrhythmia",
                        "html": "onset or worsening of arrhythmia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "peripheral myopathy (usually reversible on withdrawal)",
                        "html": "peripheral myopathy (usually reversible on withdrawal)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "peripheral neuropathy (usually reversible on withdrawal)",
                        "html": "peripheral neuropathy (usually reversible on withdrawal)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "aplastic anaemia",
                        "html": "aplastic anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "benign intracranial hypertension",
                        "html": "benign intracranial hypertension",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "bronchospasm (in patients with severe respiratory failure)",
                        "html": "bronchospasm (in patients with severe respiratory failure)",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "chronic liver disease",
                        "html": "chronic liver disease",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "cirrhosis",
                        "html": "cirrhosis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "epididymo-orchitis",
                        "html": "epididymo-orchitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "exfoliative dermatitis",
                        "html": "exfoliative dermatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "haemolytic anaemia",
                        "html": "haemolytic anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hypersensitivity",
                        "html": "hypersensitivity",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "impaired vision due to optic neuritis or optic neuropathy (including blindness)",
                        "html": "impaired vision due to optic neuritis or optic neuropathy (including blindness)",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "impotence",
                        "html": "impotence",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "sinus arrest",
                        "html": "sinus arrest",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "vasculitis",
                        "html": "vasculitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hot flushes",
                        "html": "Hot flushes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory distress syndrome",
                        "html": "respiratory distress syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sweating",
                        "html": "sweating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "anaphylaxis on rapid injection",
                        "html": "anaphylaxis on rapid injection",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Corneal microdeposits",
                "textContent": "Most patients taking amiodarone develop corneal microdeposits (reversible on withdrawal of treatment); these rarely interfere with vision, but drivers may be dazzled by headlights at night. However, if vision is impaired or if optic neuritis or optic neuropathy occur, amiodarone must be stopped to prevent blindness and expert advice sought.",
                "html": "<p>Most patients taking amiodarone develop corneal microdeposits (reversible on withdrawal of treatment); these rarely interfere with vision, but drivers may be dazzled by headlights at night. However, if vision is impaired or if optic neuritis or optic neuropathy occur, amiodarone must be stopped to prevent blindness and expert advice sought.</p>"
            },
            {
                "type": "advice",
                "title": "Thyroid function",
                "textContent": "Amiodarone contains iodine and can cause disorders of thyroid function; both hypothyroidism and hyperthyroidism can occur. Thyrotoxicosis may be very refractory, and amiodarone should usually be withdrawn at least temporarily to help achieve control; treatment with carbimazole may be required. Hypothyroidism can be treated with replacement therapy without withdrawing amiodarone if it is essential; careful supervision is required.",
                "html": "<p>Amiodarone contains iodine and can cause disorders of thyroid function; both hypothyroidism and hyperthyroidism can occur. Thyrotoxicosis may be very refractory, and amiodarone should usually be withdrawn at least temporarily to help achieve control; treatment with carbimazole may be required. Hypothyroidism can be treated with replacement therapy without withdrawing amiodarone if it is essential; careful supervision is required.</p>"
            },
            {
                "type": "advice",
                "title": "Hepatotoxicity",
                "textContent": "Amiodarone is also associated with hepatotoxicity and treatment should be discontinued if severe liver function abnormalities or clinical signs of liver disease develop.",
                "html": "<p>Amiodarone is also associated with hepatotoxicity and treatment should be discontinued if severe liver function abnormalities or clinical signs of liver disease develop.</p>"
            },
            {
                "type": "advice",
                "title": "Pulmonary toxicity",
                "textContent": "Pneumonitis should always be suspected if new or progressive shortness of breath or cough develops in a patient taking amiodarone.",
                "html": "<p>Pneumonitis should always be suspected if new or progressive shortness of breath or cough develops in a patient taking amiodarone.</p>"
            },
            {
                "type": "advice",
                "title": "Peripheral neuropathy",
                "textContent": "Fresh neurological symptoms should raise the possibility of peripheral neuropathy.",
                "html": "<p>Fresh neurological symptoms should raise the possibility of peripheral neuropathy.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Possible risk of neonatal goitre; use only if no alternative.",
                "html": "<p>Possible risk of neonatal goitre; use only if no alternative.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid; present in milk in significant amounts; theoretical risk of neonatal hypothyroidism from release of iodine.",
                "html": "<p>Avoid; present in milk in significant amounts; theoretical risk of neonatal hypothyroidism from release of iodine.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Thyroid function tests should be performed before treatment and then every 6 months. Clinical assessment of thyroid function alone is unreliable. Thyroxine (T4) may be raised in the absence of hyperthyroidism; therefore tri-iodothyronine (T3), T4, and thyroid-stimulating hormone (thyrotrophin, TSH) should all be measured. A raised T3 and T4 with a very low or undetectable TSH concentration suggests the development of thyrotoxicosis.\n\nLiver function tests required before treatment and then every 6 months.\n\nSerum potassium concentration should be measured before treatment.\n\nChest x-ray required before treatment.",
                "html": "<p>Thyroid function tests should be performed before treatment and then every 6 months. Clinical assessment of thyroid function alone is unreliable. Thyroxine (T4) may be raised in the absence of hyperthyroidism; therefore tri-iodothyronine (T3), T4, and thyroid-stimulating hormone (thyrotrophin, TSH) should all be measured. A raised T3 and T4 with a very low or undetectable TSH concentration suggests the development of thyrotoxicosis.</p><p>Liver function tests required before treatment and then every 6 months.</p><p>Serum potassium concentration should be measured before treatment.</p><p>Chest x-ray required before treatment.</p>"
            },
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "ECG monitoring and resuscitation facilities must be available.\n\nMonitor liver transaminases closely.",
                "html": "<p>ECG monitoring and resuscitation facilities must be available.</p><p>Monitor liver transaminases closely.</p>"
            },
            {
                "type": "patientParameters",
                "textContent": "If concomitant use of amiodarone with sofosbuvir and daclatasvir cannot be avoided because other anti-arrhythmics are not tolerated or contraindicated, patients should be closely monitored, particularly during the first weeks of treatment.\n\nPatients at high risk of bradycardia should be monitored continuously for 48 hours in an appropriate clinical setting after starting concomitant treatment.\n\nPatients who have stopped amiodarone within the last few months and need to start sofosbuvir and daclatasvir should be monitored.",
                "html": "<p>If concomitant use of amiodarone with sofosbuvir and daclatasvir cannot be avoided because other anti-arrhythmics are not tolerated or contraindicated, patients should be closely monitored, particularly during the first weeks of treatment.</p><p>Patients at high risk of bradycardia should be monitored continuously for 48 hours in an appropriate clinical setting after starting concomitant treatment.</p><p>Patients who have stopped amiodarone within the last few months and need to start sofosbuvir and daclatasvir should be monitored.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Cordarone X ), give continuously or intermittently in Glucose 5%. Suggested initial infusion volume 250 mL given over 20&#8211;120 minutes; for repeat infusions up to 1.2 g in max. 500 mL; should not be diluted to less than 600 micrograms/mL. See cardio-pulmonary resuscitation for details of infusion in extreme emergency. Incompatible with Sodium Chloride infusion fluids; avoid equipment containing the plasticizer di-2-ethylhexphthalate (DEHP).",
                "html": "<p>For <i>intravenous infusion</i> (<i>Cordarone X</i>\n<tm tmtype=\"reg\"/>), give continuously or intermittently in Glucose 5%. Suggested initial infusion volume 250&#8239;mL given over 20&#8211;120 minutes; for repeat infusions up to 1.2&#8239;g in max. 500&#8239;mL; should not be diluted to less than 600&#8239;micrograms/mL. See cardio-pulmonary resuscitation for details of infusion in extreme emergency. Incompatible with Sodium Chloride infusion fluids; avoid equipment containing the plasticizer di-2-ethylhexphthalate (DEHP).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For administration by mouth, tablets may be crushed and dispersed in water; injection solution should not be given orally (irritant).",
                "html": "<p>For administration<i> by mouth</i>, tablets may be crushed and dispersed in water; injection solution should <b>not</b> be given orally (irritant).</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Because of the possibility of phototoxic reactions, patients should be advised to shield the skin from light during treatment and for several months after discontinuing amiodarone; a wide-spectrum sunscreen to protect against both long-wave ultraviolet and visible light should be used.",
                "html": "<p>Because of the possibility of phototoxic reactions, patients should be advised to shield the skin from light during treatment and for several months after discontinuing amiodarone; a wide-spectrum sunscreen to protect against both long-wave ultraviolet and visible light should be used.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "textContent": "If taking amiodarone with sofosbuvir and daclatasvir, patients and their carers should be told how to recognise signs and symptoms of bradycardia and heart block and advised to seek immediate medical attention if symptoms such as shortness of breath, light-headedness, palpitations, fainting, unusual tiredness or chest pain develop.",
                "html": "<p>If taking amiodarone with sofosbuvir and daclatasvir, patients and their carers should be told how to recognise signs and symptoms of bradycardia and heart block and advised to seek immediate medical attention if symptoms such as shortness of breath, light-headedness, palpitations, fainting, unusual tiredness or chest pain develop.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution",
                "powder"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75035",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75041",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97237",
                "label": "Adverse reactions to drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78105",
                "label": "Cardiopulmonary resuscitation",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78291",
                "label": "Arrhythmias",
                "type": "treatmentSummary"
            }
        ],
        "#bnf_d1e11910": [
            {
                "id": "bnf_d1e11910",
                "label": "bnf_d1e11910",
                "type": "#bnf_d1e11910"
            }
        ],
        "#bnf_d1e12263": [
            {
                "id": "bnf_d1e12263",
                "label": "bnf_d1e12263",
                "type": "#bnf_d1e12263"
            }
        ],
        "#bnf_d1e12492": [
            {
                "id": "bnf_d1e12492",
                "label": "bnf_d1e12492",
                "type": "#bnf_d1e12492"
            }
        ],
        "#bnf_d1e12541": [
            {
                "id": "bnf_d1e12541",
                "label": "bnf_d1e12541",
                "type": "#bnf_d1e12541"
            }
        ],
        "#bnf_d1e69436": [
            {
                "id": "bnf_d1e69436",
                "label": "bnf_d1e69436",
                "type": "#bnf_d1e69436"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_1285",
                "label": "Sofosbuvir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1298",
                "label": "Simeprevir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1347",
                "label": "Daclatasvir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1379",
                "label": "Ledipasvir",
                "type": "interaction"
            }
        ],
        "#bnf_d1e68600": [
            {
                "id": "bnf_d1e68600",
                "label": "bnf_d1e68600",
                "type": "#bnf_d1e68600"
            }
        ],
        "#bnf_d1e68029": [
            {
                "id": "bnf_d1e68029",
                "label": "bnf_d1e68029",
                "type": "#bnf_d1e68029"
            }
        ],
        "#bnf_d1e67589": [
            {
                "id": "bnf_d1e67589",
                "label": "bnf_d1e67589",
                "type": "#bnf_d1e67589"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_118",
                "label": "Amiodarone",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75035",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75041",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}